|
|
Volumn 7, Issue 4, 2003, Pages 443-446
|
|
Using the MADIT II criteria for implantable cardioverter defibrillators-what is the role of the Food and Drug Administration approval?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARTICLE;
CLINICAL TRIAL;
DEFIBRILLATOR;
ECONOMICS;
FOOD AND DRUG ADMINISTRATION;
GOVERNMENT;
HUMAN;
INSURANCE;
LEGAL ASPECT;
MEDICAID;
MEDICARE;
ORGANIZATION;
PATIENT SELECTION;
SAFETY;
STANDARD;
UNITED STATES;
CLINICAL TRIALS;
DECISION MAKING, ORGANIZATIONAL;
DEFIBRILLATORS, IMPLANTABLE;
DEVICE APPROVAL;
HUMANS;
INSURANCE COVERAGE;
MEDICAID;
MEDICARE;
PATIENT SELECTION;
UNITED STATES;
UNITED STATES CENTERS FOR MEDICARE AND MEDICAID SERVICES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 4143061217
PISSN: 13852264
EISSN: None
Source Type: Journal
DOI: 10.1023/B:CEPR.0000023166.65777.6f Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|
